Radioimmunotherapy: a game-changer for advanced non-small cell lung cancer
Author Information
Author(s): Xue Huichan, Chen Yunshang, Zhou Yun
Primary Institution: Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Hypothesis
Combining immunotherapy with radiotherapy can enhance treatment outcomes for advanced non-small cell lung cancer.
Conclusion
Radioimmunotherapy shows promise in improving treatment outcomes for advanced non-small cell lung cancer by enhancing immune responses.
Supporting Evidence
- Radiotherapy can induce the 'abscopal effect', which helps reduce tumor burdens outside the treated area.
- Combining immune checkpoint inhibitors with radiotherapy has shown encouraging results in clinical trials.
- Radiotherapy increases the expression of MHC-I on tumor cells, improving immune recognition.
Takeaway
This study talks about how using radiation therapy together with immune therapy can help treat lung cancer better than using either one alone.
Methodology
This is a mini review exploring the mechanisms and clinical evidence of radioimmunotherapy in treating non-small cell lung cancer.
Limitations
Challenges in standardizing treatment protocols and managing side effects persist.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website